24345484|t|Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice.
24345484|a|Increasing evidence demonstrates that beta-amyloid (Abeta) elicits oxidative stress, which contributes to the pathogenesis and disease progression of Alzheimer's disease (AD). Thus, there is interest in developing antioxidant therapies for the prevention/treatment of cognitive decline during AD. We reported previously that puerarin has antioxidative properties in vitro. Therefore, the aim of the present study was to determine whether puerarin improves cognitive function and reduces oxidative stress in amyloid precursor protein/presenilin-1 (APP/PS1) mice, a well established AD mouse model, and explore its potential mechanism. Our results show that oral administration of puerarin significantly ameliorates cognitive impairment in APP/PS1 mice assessed by the Morris water maze (MWM) test. This was accompanied by a significant decrease in the levels of lipid peroxidation (LPO) through, at least in part, induction of nuclear factor erythroid 2-related factor 2 (Nrf2) target gene heme oxygenase 1 (HO-1) in the hippocampus of APP/PS1 transgenic mice at 9 months of age, but without altering brain Abeta burden. Furthermore, puerarin significantly activated Akt, reduced activation of glycogen synthase kinase 3beta (GSK-3beta), and induced nuclear translocation of Nrf2 in the hippocampus of APP/PS1 mice but did not alter ERK1/2 phosphorylation. Thus, puerarin may improve cognitive performance in APP/PS1 mice through activation of the Akt/GSK-3beta signaling pathway. These findings suggest that puerarin might be an attractive agent for prevention and treatment of cognitive impairment and dementia. 
24345484	0	8	Puerarin	Chemical	MESH:C033607
24345484	20	40	cognitive impairment	Disease	MESH:D003072
24345484	69	72	PS1	Gene	19164
24345484	84	88	mice	Species	10090
24345484	142	147	Abeta	Gene	11820
24345484	240	259	Alzheimer's disease	Disease	MESH:D000544
24345484	261	263	AD	Disease	MESH:D000544
24345484	358	375	cognitive decline	Disease	MESH:D003072
24345484	383	385	AD	Disease	MESH:D000544
24345484	415	423	puerarin	Chemical	MESH:C033607
24345484	528	536	puerarin	Chemical	MESH:C033607
24345484	597	622	amyloid precursor protein	Gene	11820
24345484	623	635	presenilin-1	Gene	19164
24345484	641	644	PS1	Gene	19164
24345484	646	650	mice	Species	10090
24345484	671	673	AD	Disease	MESH:D000544
24345484	674	679	mouse	Species	10090
24345484	769	777	puerarin	Chemical	MESH:C033607
24345484	804	824	cognitive impairment	Disease	MESH:D003072
24345484	832	835	PS1	Gene	19164
24345484	836	840	mice	Species	10090
24345484	1016	1059	nuclear factor erythroid 2-related factor 2	Gene	18024
24345484	1061	1065	Nrf2	Gene	18024
24345484	1079	1095	heme oxygenase 1	Gene	15368
24345484	1097	1101	HO-1	Gene	15368
24345484	1129	1132	PS1	Gene	19164
24345484	1144	1148	mice	Species	10090
24345484	1196	1201	Abeta	Gene	11820
24345484	1223	1231	puerarin	Chemical	MESH:C033607
24345484	1256	1259	Akt	Gene	11651
24345484	1283	1313	glycogen synthase kinase 3beta	Gene	56637
24345484	1315	1324	GSK-3beta	Gene	56637
24345484	1364	1368	Nrf2	Gene	18024
24345484	1395	1398	PS1	Gene	19164
24345484	1399	1403	mice	Species	10090
24345484	1422	1428	ERK1/2	Gene	26417;26413
24345484	1452	1460	puerarin	Chemical	MESH:C033607
24345484	1502	1505	PS1	Gene	19164
24345484	1506	1510	mice	Species	10090
24345484	1537	1540	Akt	Gene	11651
24345484	1541	1550	GSK-3beta	Gene	56637
24345484	1598	1606	puerarin	Chemical	MESH:C033607
24345484	1668	1688	cognitive impairment	Disease	MESH:D003072
24345484	1693	1701	dementia	Disease	MESH:D003704
24345484	Negative_Correlation	MESH:C033607	MESH:D003704
24345484	Negative_Correlation	MESH:C033607	MESH:D003072
24345484	Positive_Correlation	MESH:C033607	11651
24345484	Association	MESH:D000544	11820
24345484	Positive_Correlation	MESH:C033607	15368
24345484	Association	15368	18024
24345484	Negative_Correlation	MESH:C033607	56637
24345484	Positive_Correlation	MESH:C033607	18024

